GSK Malaysia recalls one batch of Zyrtec-D tablets


KUALA LUMPUR: GlaxoSmithKline Malaysia (GSK) has recalled its Zyrtec-D (120mg/5mg Tablets x400) Allergy Relief and Nasal Decongestant Tablets batch number 321907 with the expiry date January 2025 printed on the blister pack.

GSK, in a statement Thursday (March 30), said that the decision to recall the product is a precautionary measure after some units were found to have blisters that were incorrectly sealed.

"All tablet packs and/or blisters from this batch are being recalled at all levels in the Malaysian market, including those already dispensed to patients.

"GSK is requesting all patients who have been dispensed Zyrtec-D tablets from any in-country retail, pharmacy or healthcare outlet to return the product with immediate effect to the original point of purchase, within the next 15 days,” read the statement.

GSK also urged all healthcare professionals to immediately cease prescribing, dispensing, selling, or distributing product from this batch, while patients should seek advice from their healthcare provider on alternative treatments.

GSK added that at present, there is no evidence that any other batches are affected, and no other complaints have been received about this product from any market since 2018.

The company added that the recall does not affect Zyrtec Drop 10mg/ml, Zyrtec Solution 1mg/ml and Zyrtec Tablet 10mg, and patients may continue these medications.

Consumers or healthcare providers with questions regarding this recall may contact GSK at +603-7495 2600 on Monday to Friday from 9am to 5pm, or by e-mail at my.corporatecommunications@gsk.com.

"Patients who have been prescribed and dispensed products from this batch and have concerns should contact their healthcare provider first.

"Pharmacies, clinics and hospitals that have recalled products to be returned, please contact Zuellig Pharma Sdn Bhd at 1-800 88 1388 or email csc@zuelligpharma.com.

"Any matter related to Human Safety Information/ Adverse Event, please contact GSK Pharmacovigilance via email at drugsafetyinfo.my@gsk.com,” the statement added. - Bernama

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Seoul hit by heaviest snowfall in over 100 years
Azmin Ali appointed Bersatu sec-gen
Polygamy can arrest decline in national birth rate, suggests Opposition MP
We only want what's ours, says Sanusi on Kedah's claim over Penang
Penang state assembly approves Budget 2025, adjourns
Number of flood victims increases in K'tan, T'ganu, Kedah and Perlis
Ananda Krishnan a key figure in developing Malaysian media, telco and entertainment industries
Negri Sembilan's 2025 Budget among six Bills passed by state assembly
13 Muar pupils suffer food poisoning, school canteen shut down for two weeks
'Kelantan floods worse than 2014's 'bah kuning' disaster' (with picture gallery)

Others Also Read